Scouting For Girls frontman Roy Stride says it would be his "dream" to keep playing shows and making music to the day he dies.

'Paddington in Peru' is heading to UK cinemas on November 8, 2024, more than two months ahead of the US, when the motion picture will be in theatres from January 17th.

Lauryn Hill was forced to postpone a concert in Philadelphia this week on doctor's orders, to prevent "serious strain or damage" to her vocal cords, but she is still planning to play in Toronto on Thursday (26.10.23).

Foo Fighters frontman Dave Grohl made a surprise appearance with The Breeders at a festival in Austin, Texas

The next film in Tom Cruise's Mission: Impossible franchise has been delayed by a year and now won't hit cinemas until May 2025

Novelists have used everything from real killers to newsworthy hostage situations to literal white whales to craft their fiction.

It’s never a bad time to talk about the baseball scene in ‘Twilight.’

The pronunciations of names like ‘Yves’ and ‘Geneviève’ aren’t hard once you’ve heard them a few times.

PJ Harvey is returning to London for a one-off concert this summer.

Rebecca Adlington said she is “truly heartbroken” after suffering a late-stage miscarriage. The double Olympic gold medal swimmer found out about the devastating loss at a routine 20-week scan, sharing the news in a post on Instagram yesterday evening. “I don’t really have the words right now but unfortunately we went for our 20 week scan this week and they found no heartbeat. I gave birth to our angel, Harper on Friday at 7pm. We held her, and had time with her. We will forever love her and remember her always,” Adlington, 34, said. After thanking staff at Wythenshawe Hospital for their “kindness and care”, she added: “I don’t have the strength or words right now and don’t feel ready to share this news. However, I can’t pretend to be ok or fake a smile. I can’t have people ask me how pregnancy is or when I am due as I still look pregnant. I don’t have the strength to tell this news individually. “We are so truly heartbroken. Our beautiful girl. Rest in peace.” Adlington – who shares son Albie, two, with her husband Andy Parsons and has an eight-year-old daughter, Summer, from her previous marriage with Harry Needs – previously revealed she’d had a miscarriage 12 weeks into her pregnancy last August, resulting in emergency surgery. And as her Instagram post this week highlights, one of the many difficult things about losing a baby is telling other people. So, how can people respond supportively when a friend, relative or colleague shares news of a baby loss? Showing empathy “It’s about showing empathy as much as you possibly can, showing some form of understanding, and really just being there to listen to them,” Rochelle Love, a midwife working with baby loss charity Tommy’s, told the PA news agency. A late miscarriage is one which happens between 14-24 weeks of pregnancy, and is less common than early-stage miscarriage, occurring in an estimated 1-2% of pregnancies, Love explained. “We don’t always know why these miscarriages happen. They can be for a multitude of reasons, and the sad thing for expectant parents is that we may not always find a definite cause,” she added. “It may not necessarily be related to previous miscarriage.” Take care with ‘helpful’ comments Friends and family may try to comfort someone who’s lost a baby with well-meaning but sometimes way off-the-mark ‘helpful’ comments. Love said it’s crucial to be very careful about what you say. “I don’t think it’s ever up to us to make assumptions, and especially do not make comments like: ‘Don’t worry, you can have another baby’, ‘Don’t worry, you can try again’, or, ‘You were only 20 weeks pregnant’,” Love advised. “I think sometimes people just don’t know what else to say, so they make these throwaway comments, which are not necessarily the best things to say when someone’s grieving. It’s not up to us to say [these things] – how do you know, for example, that they can have another baby? Think about what you’re going to say before you speak to someone who’s had a loss.” Be mindful of terminology Remember this isn’t just a foetus to the grieving parents – it’s their child, and it can be very important to talk about it as such. Love said: “Address the baby as their baby, and if the baby has a name, then use it. Be very careful of the words you use.” Be there for them Instead of offering up platitudes, Love said it’s often better to just let people know you’re there if they need you. “Just let them know you’re there for them – you’re there if they want to speak, or if they just want to sit in silence – you’re available to be their support if and when they should need it,” she explained. Don’t forget their partner Love stresses that any kind of support needs to be extended to the partner as well. “Sometimes the partner is ignored and we just focus on the pregnant person, but the partner is the pregnant person’s closest support and they’ve also lost their baby and are also grieving,” she said. “I always advise anyone who’s had an unfortunate loss that if they decide to go for grief counselling, they should make their partner a part of that process as well, so they can go on that grief and healing journey together.” Remember everyone will grieve differently Loss and grief is experienced differently by everyone. “How I may grieve a pregnancy loss may be very different from how somebody else might grieve,” said Love – so it’s important to let people do things their way and at their own pace. Think about offering them helpIf you are close with them, offer practical help if you feel they may welcome it. Love said this could mean “getting someone’s groceries for them because they don’t feel they can face getting dressed and going out, or cleaning the house – anything at all could be very well received.” Tommy’s helpline is on 0800 014 7800 Read More What you need to know about new research into treating cervical cancer How to do Halloween make up and still take care of your skin Which houseplants best suit your star sign? 5 of the hottest new perfume launches for autumn/winter Consistent lack of sleep may increase risk of future depressive symptoms – study World Osteoporosis Day: The risk factors and early warning signs everyone needs to know about

Heavy metal drummer Mikkey Dee says reforming Motorhead is “impossible” without late frontman Lemmy but he has vowed to play the band's songs live.

Using existing drugs to treat cervical cancer before standard treatment could lead to a 35% reduction in the risk of relapse or death, a new study suggests. Researchers from the UCL Cancer Institute and UCLH looked into whether a short course of induction chemotherapy (IC), where a drug is used to destroy as many cancer cells as possible, before chemoradiation (CRT), could help with this. Here’s everything you need to know about the findings… What is cervical cancer? According to the NHS website, cervical cancer is a type of cancer found anywhere near the cervix – the opening between the vagina and the womb (uterus), which is also known as the neck of the womb. Most cervical cancers grow very slowly and are caused by an infection from specific types of human papillomavirus (HPV) and mostly affect women under the age of 45. According to Jo’s Cervical Cancer Trust, symptoms include vaginal bleeding that is unusual to you, changes to vaginal discharge, discomfort during sex and pain in your lower back or pelvis. Changes to cells can be spotted by a cervical screening, and then treated before they turn into cancer. There are around 3,200 new cases every year in the UK, with the five-year survival rate being around 70%, according to Cancer Research UK. CRT has been the standard treatment for cervical cancer patients since 1999, but even though there have been overall significant developments in radiation therapy techniques, up to 30% of people experience their cancer coming back. What did the research involve? Over a 10-year period, 500 patients who had been diagnosed with cervical cancer – that was large enough to see without a microscope but hadn’t spread to other parts of the body – took part in the Interlace trial at hospitals in the UK, Mexico, India, Italy and Brazil. Researchers looked into whether a short course of IC before CRT could reduce rates of relapse and death. What results were found? After five years, researchers discovered that 80% of the people who received a combination of chemotherapy and radiotherapy were alive, whilst 73% had not seen their cancer return or spread. A major benefit, according to researchers, is that it can be incorporated into standard of care treatment relatively quickly, because cheap, accessible and already-approved ingredients such as carboplatin and paclitaxel are needed for IC. “Our trial shows that this short course of additional chemotherapy delivered immediately before the standard CRT can reduce the risk of the cancer returning or death by 35%,” said Dr Mary McCormack, lead investigator of the trial from UCL Cancer Institute and UCLH. “This is the biggest improvement in outcome in this disease in over 20 years. “I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere. “We couldn’t have done this without the generous support of Cancer Research UK.” Why is the research important? Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “Timing is everything when you’re treating cancer. The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial. “A growing body of evidence is showing the value of additional rounds of chemotherapy before other treatments like surgery and radiotherapy in several other cancers. “Not only can it reduce the chances of cancer coming back, it can be delivered quickly using drugs already available worldwide. “We’re excited for the improvements this trial could bring to cervical cancer treatment and hope short courses of induction chemotherapy will be rapidly adopted in the clinic.”